Among 200 patients with Brugada syndrome, 2.5% had PKP2 missense mutations that experimentally caused decreased sodium current, suggesting PKP2 mutations may be a molecular substrate for the disease.
Observational (n=200)
Do PKP2 missense mutations cause sodium current deficit and associate with a Brugada syndrome phenotype?
PKP2 missense mutations can cause sodium current deficits and may serve as a molecular substrate for Brugada syndrome, even in the absence of overt structural features of arrhythmogenic cardiomyopathy.
BACKGROUND: Brugada syndrome (BrS) primarily associates with the loss of sodium channel function. Previous studies showed features consistent with sodium current (INa) deficit in patients carrying desmosomal mutations, diagnosed with arrhythmogenic cardiomyopathy (or arrhythmogenic right ventricular cardiomyopathy). Experimental models showed correlation between the loss of expression of desmosomal protein plakophilin-2 (PKP2) and reduced INa. We hypothesized that PKP2 variants that reduce INa could yield a BrS phenotype, even without overt structural features characteristic of arrhythmogenic right ventricular cardiomyopathy. METHODS AND RESULTS: We searched for PKP2 variants in the genomic DNA of 200 patients with a BrS diagnosis, no signs of arrhythmogenic cardiomyopathy, and no mutations in BrS-related genes SCN5A, CACNa1c, GPD1L, and MOG1. We identified 5 cases of single amino acid substitutions. Mutations were tested in HL-1-derived cells endogenously expressing NaV1.5 but made deficient in PKP2 (PKP2-KD). Loss of PKP2 caused decreased INa and NaV1.5 at the site of cell contact. These deficits were restored by the transfection of wild-type PKP2, but not of BrS-related PKP2 mutants. Human induced pluripotent stem cell cardiomyocytes from a patient with a PKP2 deficit showed drastically reduced INa. The deficit was restored by transfection of wild type, but not BrS-related PKP2. Super-resolution microscopy in murine PKP2-deficient cardiomyocytes related INa deficiency to the reduced number of channels at the intercalated disc and increased separation of microtubules from the cell end. CONCLUSIONS: This is the first systematic retrospective analysis of a patient group to define the coexistence of sodium channelopathy and genetic PKP2 variations. PKP2 mutations may be a molecular substrate leading to the diagnosis of BrS.
Cerrone et al. (Wed,) conducted a observational in Brugada syndrome (n=200). PKP2 mutations was evaluated on Presence of PKP2 variants (single amino acid substitutions). Among 200 patients with Brugada syndrome, 2.5% had PKP2 missense mutations that experimentally caused decreased sodium current, suggesting PKP2 mutations may be a molecular substrate for the disease.